Abstract
This research service covers the U.S. injectable drug pipeline in 2009.
Included are technology trends, Phase III pipeline analysis, selected Phase II
and I pipeline analysis. The market is segmented by injectable drug delivery
route: subcutaneous injectables, intravenous injectables, intramuscular
injectables, and others. Major market challenges, drivers, and restraints and
identified and discussed as well as hot topics and trends relating to
injectable drug development.
|